查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2008438

彈性成像市場：按產品、組件、技術、最終用戶和應用分類－2026-2032年全球市場預測

Elastography Imaging Market by Product, Component, Technology, End User, Application - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 194 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，彈性成像市場價值將達到 57 億美元，到 2026 年將成長至 63.1 億美元，到 2032 年將達到 115.8 億美元，複合年成長率為 10.65%。

主要市場統計數據
基準年 2025 57億美元
預計年份：2026年 63.1億美元
預測年份 2032 115.8億美元
複合年成長率 (%) 10.65%

全面概述彈性成像技術，拓展其臨床效用，以及在臨床環境中廣泛應用的操作要求。

彈性成像技術正迅速成為多個臨床領域中至關重要的診斷方法，使臨床醫生能夠非侵入性地量化組織的機械特性，從而補充傳統的解剖成像技術。磁振造影彈性成像（MR）和超音波彈性成像各有其獨特的技術優勢。 MR彈性成像可提供高解析度的全器官硬度圖譜，是評估複雜肝臟和腫瘤的理想選擇。而超音波彈性成像則可提供即時、經濟高效的照護現場評估，並可無縫整合到常規臨床工作流程中。隨著人們對早期檢測、監測治療效果和微創分期的日益重視，這些互補的影像方式正將其臨床效用從肝臟擴展到乳房、甲狀腺和肌肉骨骼組織。

技術融合、數據驅動的影像解讀和基於價值的醫療如何改變彈性成像領域的臨床工作流程和供應商策略。

隨著技術的成熟和臨床需求的不斷演變，彈性成像領域正經歷著變革。剪切波生成、磁振造影彈性成像的運動編碼策略以及韌體驅動的超音波換能器設計改進等技術的進步，顯著提高了影像的保真度和可重複性。同時，先進分析技術和機器學習的融合，增強了特徵提取和自動解讀能力，降低了對操作者的依賴性，並加快了臨床決策速度。這些技術突破與系統模組化的改進和軟體主導的更新相輔相成，從而實現了演算法的改進和臨床通訊協定的快速部署。

對修訂後的定價結構對彈性成像硬體、軟體和服務交付模式的多方面供應鏈和成本影響進行評估。

2025年實施的新關稅措施對整個彈性成像供應鏈產生了累積影響，需要謹慎的策略性應對。感測器、運動驅動器和專用磁共振線圈等硬體組件對進口關稅和運輸成本的波動特別敏感，這可能會使原始設備製造商 (OEM) 和系統整合商的採購流程更加複雜。軟體授權和基於雲端的分析正面臨著營運成本增加和跨境資訊服務可能受到限制的間接成本壓力。包括現場校準和預防性保養的服務交付模式也可能受到物流成本上升和供應商部署策略變化的影響。

綜合細分分析揭示了產品、組件、最終用戶、技術和臨床應用如何整合並決定部署優先順序。

精細的細分觀點有助於揭示臨床價值和商業性機會在產品、組件、終端用戶、技術和應用等維度上的交匯點。產品差異化主要體現在磁振造影彈性成像（MRE）和超音波彈性成像（UE）。 MRE有助於評估複雜的整體器官，而UE則可在病床和門診進行即時、攜帶式評估。組件層面的趨勢揭示了清晰的戰略重點：硬體投資側重於換能器和線圈的創新；軟體投資側重於分析功能和工作流程整合；服務側重於培訓、校準和臨床支持，以確保成功部署。

美洲、歐洲、中東和非洲以及亞太地區的區域採用趨勢和戰略挑戰，這些挑戰正在影響商業化和臨床整合。

區域趨勢對美洲、歐洲、中東和非洲以及亞太地區的醫療技術應用路徑、監管預期和商業化策略有顯著影響。在美洲，先進的醫療基礎設施、完善的報銷體係以及高度集中的研究機構推動了磁振造影（MRI）和超音波彈性成像技術的早期應用，尤其是在肝病管理和腫瘤學應用方面。該地區的採購方通常要求提供可靠的檢驗研究、跨機構的互通性以及能夠擴展到整個醫院網路的服務交付模式。

決定硬體創新、分析平台和臨床服務差異化領域領導地位的競爭性策略行動和夥伴關係模式。

彈性成像領域的競爭格局呈現出成熟醫療影像設備製造商、專業軟體創新者以及專注於照護現場和人工智慧驅動解決方案的參與企業相互交鋒的態勢。關鍵策略舉措包括提升專有硬體效能，同時投資於能夠將原始數據硬度指標轉化為臨床可用報告的分析平台。與學術機構和臨床網路的合作對於循證醫學證據的生成和指南的製定仍然至關重要，並有助於推動保守派相關人員接受該技術。

為供應商和醫療保健領導者提供實用策略指導，以增強產品模組化、證據產生、供應鏈彈性和在地化商業化。

產業領導者應推動一系列切實可行、以證據為基礎的舉措，以確保臨床意義和商業性韌性。首先，他們應優先考慮模組化產品架構，允許分階段升級感測器技術、軟體分析和雲端服務，而無需對整個系統進行徹底改造，從而維護現有部署基礎設施並支援更順暢的資本規劃。其次，他們應投資嚴格的臨床驗證項目，並針對優先適應症（例如肝纖維化分期和乳房病變特徵分析）創建真實世界臨床檢驗，以滿足特定支付方和指南的要求。這些證據基礎將在確保以價值為導向的醫療保健系統做出有利的採購決策方面發揮關鍵作用。

本文概述了用於創建彈性成像影像整合的調查方法，包括基於三角測量的定性研究和次要研究、專家檢驗，以及對分析嚴謹性的描述。

為確保證據基礎的穩健性和說服力，本研究採用三角測量調查方法，結合專家訪談、一手質性研究和針對性的二手分析。關鍵資訊來源包括對臨床專家、生物醫學工程師、採購經理和服務人員的結構化訪談，從而深入了解設備性能、工作流程整合和部署障礙。此外，本觀點還系統性地回顧了監管申報文件、同行評審的臨床文獻和公開的技術文檔，從而將技術能力和臨床結果置於具體的背景中進行分析。

綜合分析和策略展望，概述了將彈性成像技術的進步轉化為永續的臨床應用和可衡量的醫療價值所必需的實際步驟。

彈性成像技術正處於策略轉折點，技術進步、臨床需求和商業策略必須協調一致，才能最大限度地發揮其在多種適應症中的潛力。磁振造影和超音波彈性成像技術的進步使得組織表徵更加精準，而分析功能和互通軟體的整合正在降低其常規臨床應用的門檻。同時，價值鏈壓力和不斷變化的法規結構要求供應商和醫療機構採用穩健的營運模式，並投資於能夠證明其臨床和經濟價值的證據。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：彈性成像市場：依產品分類

  • 磁振造影彈性成像
  • 超音波成像

第9章：彈性成像市場：依組件分類

  • 硬體
  • 服務
  • 軟體

第10章：彈性成像市場：依技術分類

  • 剪切波彈性成像
  • 應變彈性成像

第11章：彈性成像市場：依最終用戶分類

  • 學術研究機構
  • 診斷影像中心
  • 醫院

第12章：彈性成像市場：依應用領域分類

  • 乳腺影像
  • 肝臟影像
  • 肌肉骨骼影像
  • 甲狀腺影像

第13章：彈性成像市場：按地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章 彈性成像市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章：彈性成像市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章：美國彈性成像市場

第17章：中國彈性成像市場

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Advanced Instrumentations
  • BK Medical Holding Company, Inc.
  • Boston Scientific Corporation
  • Canon Medical Systems Corporation
  • CHISON Medical Technologies Co., Ltd.
  • Clarius Mobile Health Corp.
  • Dawei Medical（Jiangsu）Corp., Ltd.
  • Esaote SpA
  • Fujifilm Holdings Corporation
  • GE HealthCare Technologies Inc.
  • Hitachi, Ltd.
  • Jiangsu Aegean Technology Co.,Ltd
  • Koninklijke Philips NV
  • Mindray Medical International Limited
  • Neusoft Medical Systems Co., Ltd.
  • Resoundant, Inc.
  • Samsung Medison Co., Ltd.
  • Shantou Institute of Ultrasonic Instruments Co., Ltd.
  • Shimadzu Corporation
  • Siemens AG
  • SonoScape Medical Corp.
  • SternMed GmbH
  • SuperSonic Imagine SA
  • Toshiba Corporation
  • Zimmer MedizinSysteme GmbH
Product Code: MRR-C002B1C9967A

The Elastography Imaging Market was valued at USD 5.70 billion in 2025 and is projected to grow to USD 6.31 billion in 2026, with a CAGR of 10.65%, reaching USD 11.58 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 5.70 billion
Estimated Year [2026] USD 6.31 billion
Forecast Year [2032] USD 11.58 billion
CAGR (%) 10.65%

Comprehensive orientation to elastography imaging modalities, clinical utility expansion, and the operational prerequisites for widespread clinical adoption

Elastography imaging has emerged as a pivotal diagnostic modality across multiple clinical domains, enabling clinicians to quantify tissue mechanical properties noninvasively and thereby augment traditional anatomical imaging. Magnetic resonance elastography and ultrasound elastography each bring distinct technical strengths: MR elastography delivers high-resolution, whole-organ stiffness mapping well suited for complex hepatic and oncologic assessments, while ultrasound elastography provides real-time, cost-effective point-of-care evaluation that integrates seamlessly into routine clinical workflows. These complementary modalities are expanding clinical utility beyond the liver to include breast, thyroid, and musculoskeletal tissues, driven by an emphasis on early detection, therapy response monitoring, and minimally invasive disease staging.

Transitioning from research into routine practice requires alignment among clinical evidence, reimbursement frameworks, device interoperability, and operator training. Consequently, stakeholders across academia, diagnostic centers, and hospitals are now prioritizing comparative clinical trials, standardization of acquisition protocols, and integration of elastography outputs into electronic health records. As a result, technology developers and clinical leaders are converging on shared priorities: improving quantitative reproducibility, reducing time-to-result, and enhancing interpretive decision support through analytics. Taken together, these dynamics underscore an accelerating shift from niche research applications toward broader clinical adoption guided by evidence-based practice and operational efficiency.

How converging technology advances, data-driven interpretation, and value-based care are reshaping clinical workflows and vendor strategies in elastography

The elastography landscape is undergoing transformative shifts as technological maturation intersects with evolving clinical priorities. Advances in shear wave generation, motion-encoding strategies for MR elastography, and firmware-driven improvements in ultrasound transducer design have materially improved image fidelity and reproducibility. Concurrently, the integration of advanced analytics and machine learning is enhancing feature extraction and automated interpretation, which reduces operator dependence and accelerates clinical decision-making. These technical breakthroughs are complemented by improvements in system modularity and software-driven updates, enabling more rapid deployment of algorithmic enhancements and clinical protocols.

Beyond pure technology, the care delivery environment is shifting toward value-based models that reward diagnostic precision and reduced downstream costs. This is reshaping procurement preferences: healthcare providers are increasingly seeking solutions that demonstrate measurable clinical impact, predictable total cost of ownership, and robust service ecosystems. In parallel, regulatory pathways are evolving to accommodate software as a medical device and AI-enabled diagnostics, creating both opportunities and compliance obligations for vendors. Collectively, these forces are accelerating the transition from isolated research applications to integrated diagnostic pathways that prioritize longitudinal patient monitoring, cross-modality data fusion, and scalable service offerings.

Assessing the multifaceted supply chain and cost implications of altered tariff regimes on elastography hardware, software, and service delivery models

The introduction of new tariff measures in 2025 has produced cumulative effects across the elastography supply chain that merit careful strategic response. Hardware components such as transducers, motion drivers, and specialized magnetic resonance coils are particularly sensitive to changes in import duties and shipping costs, with the potential to increase procurement complexity for original equipment manufacturers and system integrators. Software licensing and cloud-based analytics face indirect cost pressures through increased operational expenses and potential constraints on cross-border data services. Service delivery models, including on-site calibration and preventive maintenance, may also be affected by higher logistics costs and altered vendor deployment strategies.

In response, stakeholders are adjusting sourcing strategies and contractual terms to preserve clinical access and margin structures. Some manufacturers are prioritizing localization of production or establishing alternative manufacturing footprints to mitigate tariff exposure. Others are shifting to subscription-based software agreements and remote diagnostics capabilities to offset higher hardware costs and maintain predictable revenue streams. For clinical providers, the tariffs underscore the importance of procurement agility, longer-term supplier partnerships, and careful life-cycle cost analysis. By adopting adaptive sourcing, enhanced inventory planning, and closer vendor collaboration, organizations can reduce disruption and maintain continuity of care without eroding clinical outcomes.

Integrated segmentation analysis revealing how product, component, end-user, technology, and clinical applications converge to define adoption priorities

A nuanced segmentation perspective helps clarify where clinical value and commercial opportunity intersect across product, component, end-user, technology, and application dimensions. Product differentiation is primarily expressed through magnetic resonance elastography, which serves complex whole-organ assessments, and ultrasound elastography, which provides real-time, portable evaluation at the bedside or in outpatient clinics. Component-level dynamics reveal distinct strategic emphases: hardware investments focus on transducer and coil innovation, software investments prioritize analytics and workflow integration, and services concentrate on training, calibration, and clinical support to ensure reliable adoption.

End-user profiles shape procurement criteria and utilization patterns. Academic research institutes emphasize experimental flexibility and integration with longitudinal studies, diagnostic imaging centers prioritize throughput and cost-effectiveness, and hospitals demand enterprise-grade interoperability and service coverage across multiple clinical departments. From a technology standpoint, shear wave elastography provides quantitative stiffness mapping with rapid acquisition, while strain elastography offers operator-applied compression techniques that are valuable in focal lesion characterization. Application areas further refine market needs: breast imaging requires high-resolution lesion differentiation and integration with biopsy workflows, liver imaging benefits from whole-organ fibrosis mapping and therapy monitoring, musculoskeletal imaging demands portability and dynamic assessment of soft-tissue biomechanics, and thyroid imaging calls for sensitive lesion characterization that can influence fine-needle aspiration decisions. Integrating these segmentation dimensions enables stakeholders to align product roadmaps, clinical validation strategies, and commercial models with clear end-user value propositions.

Regional adoption dynamics and strategic imperatives across the Americas, Europe Middle East and Africa, and Asia-Pacific that shape commercialization and clinical integration

Regional dynamics exert a profound influence on adoption pathways, regulatory expectations, and commercialization strategies across the Americas, Europe, Middle East & Africa, and Asia-Pacific. In the Americas, the combination of advanced healthcare infrastructure, established reimbursement frameworks, and a high concentration of research institutions has driven early adoption of both MR and ultrasound elastography, with a particular focus on liver disease management and oncologic applications. Buyers in this region commonly seek robust validation studies, enterprise interoperability, and service commitments that scale across hospital networks.

The Europe, Middle East & Africa landscape features heterogeneity in regulatory and reimbursement environments that favors flexible commercialization models and partnership-driven deployment. European health systems emphasize clinical guidelines and multicenter validation, which encourages collaboration between vendors and clinical consortia. Meanwhile, several Middle Eastern and African markets are prioritizing capacity building and diagnostic modernization, creating opportunities for tailored service contracts and mobile solutions.

Asia-Pacific is characterized by rapid clinical adoption, a substantial manufacturing presence for ultrasound components, and dynamic private healthcare sectors that accelerate commercialization of innovative diagnostics. Local regulatory reforms and expanding point-of-care networks have supported uptake in liver and breast imaging applications, while cost-sensitive procurement in many markets has heightened demand for scalable, modular solutions. Across regions, successful strategies combine localized evidence generation, adaptive pricing, and close collaboration with clinical champions to navigate diverse institutional priorities and regulatory regimes.

Competitive strategic behaviors and partnership models that determine leadership in hardware innovation, analytic platforms, and clinical service differentiation

Competitive dynamics in elastography are defined by a blend of established medical imaging manufacturers, specialized software innovators, and emerging entrants focused on point-of-care and AI-driven solutions. Key strategic plays include advancing proprietary hardware capabilities while simultaneously investing in analytic platforms that translate raw stiffness metrics into clinically actionable reports. Partnerships with academic centers and clinical networks remain a critical avenue for evidence generation and guideline development, supporting adoption among conservative procurement stakeholders.

In addition, companies that emphasize service excellence-through robust training programs, remote diagnostics, and lifecycle management-are differentiating on total cost of ownership and clinical uptime. Software vendors that prioritize open interfaces and standards-based integration with PACS and electronic health records facilitate smoother clinical workflows and accelerate buyer confidence. Strategic collaborations, licensing arrangements, and targeted acquisitions are typical routes for expanding intellectual property portfolios and accelerating time-to-market for new algorithms and device iterations. For clinical leaders, vendor selection increasingly reflects a balance between technical performance, evidence of clinical utility, and long-term service commitments that support scalability across care pathways.

Actionable strategic guidance for vendors and healthcare leaders to enhance product modularity, evidence generation, supply chain resilience, and regionally tailored commercialization

Industry leaders should pursue a set of pragmatic, evidence-driven actions to secure clinical relevance and commercial resilience. First, prioritize modular product architectures that allow incremental upgrades to transducer technology, software analytics, and cloud services without necessitating full system replacement, thereby preserving existing installed bases and supporting smoother capital planning. Second, invest in rigorous clinical validation programs and real-world evidence generation that address specific payer and guideline requirements for priority applications such as liver fibrosis staging and breast lesion characterization. This evidence base will be instrumental in securing favorable procurement decisions in health systems that emphasize value.

Third, strengthen supply chain resilience through diversification of manufacturing footprints, nearshoring options where feasible, and strategic inventory buffering to mitigate the operational impacts of tariff changes and logistics disruptions. Fourth, develop flexible commercial models that blend hardware sales with SaaS and managed service offerings to align vendor incentives with customer outcomes. Fifth, cultivate regional commercialization strategies that reflect local regulatory environments, reimbursement pathways, and clinical workflows, and establish deep partnerships with academic centers and key opinion leaders to accelerate adoption. Implementing these recommendations requires cross-functional coordination among R&D, regulatory, clinical affairs, and commercial teams to translate technological advantages into sustained clinical and financial outcomes.

Methodological overview describing triangulated qualitative and secondary research, expert validation, and analytical rigour used to produce the elastography imaging synthesis

This research synthesis was developed using a triangulated methodology that combines expert interviews, primary qualitative inquiry, and targeted secondary analysis to ensure a robust and defensible evidence base. Primary inputs included structured interviews with clinical specialists, biomedical engineers, procurement leads, and service professionals who provided granular insights into device performance, workflow integration, and adoption barriers. These perspectives were complemented by a systematic review of regulatory filings, peer-reviewed clinical literature, and publicly available technical documentation to contextualize technological capabilities and clinical outcomes.

Analytic processes incorporated cross-validation between qualitative insights and documented technology performance metrics, with particular attention to reproducibility and operator dependence. The methodology also included assessment of supply chain and policy developments through industry communications and trade publications, followed by scenario testing to understand operational implications. All findings were synthesized through iterative expert review to reconcile divergent views and surface practical recommendations. Limitations include the evolving nature of regulatory guidance and the rapid pace of algorithm development, which make ongoing validation and periodic updates essential for maintaining the research relevance.

Synthesis and strategic outlook outlining the practical steps needed to translate elastography technology advances into sustained clinical adoption and measurable healthcare value

Elastography imaging stands at a strategic inflection point where technical evolution, clinical needs, and commercial strategy must align to realize its full potential across multiple indications. Advances in MR and ultrasound elastography are enabling more precise tissue characterization, and the integration of analytics and interoperable software is lowering barriers to routine clinical use. At the same time, supply chain pressures and evolving regulatory frameworks require vendors and providers to adopt resilient operational models and to invest in evidence that demonstrates clinical and economic value.

Looking ahead, success will hinge on collaborative approaches that unite technology developers, clinical investigators, and health system decision-makers around common measurement standards, multicenter validation, and training programs that ensure consistent acquisition and interpretation. By prioritizing modular product design, flexible commercial models, and locally relevant evidence generation, stakeholders can accelerate adoption in both established and emerging healthcare markets. In short, the pathway to broader clinical impact is attainable through disciplined innovation, strategic partnerships, and sustained attention to real-world utility.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Elastography Imaging Market, by Product

  • 8.1. Magnetic Resonance Elastography
  • 8.2. Ultrasound Elastography

9. Elastography Imaging Market, by Component

  • 9.1. Hardware
  • 9.2. Services
  • 9.3. Software

10. Elastography Imaging Market, by Technology

  • 10.1. Shear Wave Elastography
  • 10.2. Strain Elastography

11. Elastography Imaging Market, by End User

  • 11.1. Academic Research Institutes
  • 11.2. Diagnostic Imaging Centers
  • 11.3. Hospitals

12. Elastography Imaging Market, by Application

  • 12.1. Breast Imaging
  • 12.2. Liver Imaging
  • 12.3. Musculoskeletal Imaging
  • 12.4. Thyroid Imaging

13. Elastography Imaging Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Elastography Imaging Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Elastography Imaging Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Elastography Imaging Market

17. China Elastography Imaging Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Advanced Instrumentations
  • 18.6. BK Medical Holding Company, Inc.
  • 18.7. Boston Scientific Corporation
  • 18.8. Canon Medical Systems Corporation
  • 18.9. CHISON Medical Technologies Co., Ltd.
  • 18.10. Clarius Mobile Health Corp.
  • 18.11. Dawei Medical (Jiangsu) Corp., Ltd.
  • 18.12. Esaote SpA
  • 18.13. Fujifilm Holdings Corporation
  • 18.14. GE HealthCare Technologies Inc.
  • 18.15. Hitachi, Ltd.
  • 18.16. Jiangsu Aegean Technology Co.,Ltd
  • 18.17. Koninklijke Philips N.V.
  • 18.18. Mindray Medical International Limited
  • 18.19. Neusoft Medical Systems Co., Ltd.
  • 18.20. Resoundant, Inc.
  • 18.21. Samsung Medison Co., Ltd.
  • 18.22. Shantou Institute of Ultrasonic Instruments Co., Ltd.
  • 18.23. Shimadzu Corporation
  • 18.24. Siemens AG
  • 18.25. SonoScape Medical Corp.
  • 18.26. SternMed GmbH
  • 18.27. SuperSonic Imagine SA
  • 18.28. Toshiba Corporation
  • 18.29. Zimmer MedizinSysteme GmbH

LIST OF FIGURES

  • FIGURE 1. GLOBAL ELASTOGRAPHY IMAGING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL ELASTOGRAPHY IMAGING MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL ELASTOGRAPHY IMAGING MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL ELASTOGRAPHY IMAGING MARKET SIZE, BY PRODUCT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL ELASTOGRAPHY IMAGING MARKET SIZE, BY COMPONENT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL ELASTOGRAPHY IMAGING MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL ELASTOGRAPHY IMAGING MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL ELASTOGRAPHY IMAGING MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL ELASTOGRAPHY IMAGING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ELASTOGRAPHY IMAGING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL ELASTOGRAPHY IMAGING MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES ELASTOGRAPHY IMAGING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA ELASTOGRAPHY IMAGING MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL ELASTOGRAPHY IMAGING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL ELASTOGRAPHY IMAGING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL ELASTOGRAPHY IMAGING MARKET SIZE, BY MAGNETIC RESONANCE ELASTOGRAPHY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL ELASTOGRAPHY IMAGING MARKET SIZE, BY MAGNETIC RESONANCE ELASTOGRAPHY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL ELASTOGRAPHY IMAGING MARKET SIZE, BY MAGNETIC RESONANCE ELASTOGRAPHY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL ELASTOGRAPHY IMAGING MARKET SIZE, BY ULTRASOUND ELASTOGRAPHY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL ELASTOGRAPHY IMAGING MARKET SIZE, BY ULTRASOUND ELASTOGRAPHY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL ELASTOGRAPHY IMAGING MARKET SIZE, BY ULTRASOUND ELASTOGRAPHY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL ELASTOGRAPHY IMAGING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL ELASTOGRAPHY IMAGING MARKET SIZE, BY HARDWARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL ELASTOGRAPHY IMAGING MARKET SIZE, BY HARDWARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL ELASTOGRAPHY IMAGING MARKET SIZE, BY HARDWARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL ELASTOGRAPHY IMAGING MARKET SIZE, BY SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL ELASTOGRAPHY IMAGING MARKET SIZE, BY SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL ELASTOGRAPHY IMAGING MARKET SIZE, BY SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL ELASTOGRAPHY IMAGING MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL ELASTOGRAPHY IMAGING MARKET SIZE, BY SOFTWARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL ELASTOGRAPHY IMAGING MARKET SIZE, BY SOFTWARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL ELASTOGRAPHY IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL ELASTOGRAPHY IMAGING MARKET SIZE, BY SHEAR WAVE ELASTOGRAPHY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL ELASTOGRAPHY IMAGING MARKET SIZE, BY SHEAR WAVE ELASTOGRAPHY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL ELASTOGRAPHY IMAGING MARKET SIZE, BY SHEAR WAVE ELASTOGRAPHY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL ELASTOGRAPHY IMAGING MARKET SIZE, BY STRAIN ELASTOGRAPHY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL ELASTOGRAPHY IMAGING MARKET SIZE, BY STRAIN ELASTOGRAPHY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL ELASTOGRAPHY IMAGING MARKET SIZE, BY STRAIN ELASTOGRAPHY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL ELASTOGRAPHY IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL ELASTOGRAPHY IMAGING MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL ELASTOGRAPHY IMAGING MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL ELASTOGRAPHY IMAGING MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL ELASTOGRAPHY IMAGING MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL ELASTOGRAPHY IMAGING MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL ELASTOGRAPHY IMAGING MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL ELASTOGRAPHY IMAGING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL ELASTOGRAPHY IMAGING MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL ELASTOGRAPHY IMAGING MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL ELASTOGRAPHY IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL ELASTOGRAPHY IMAGING MARKET SIZE, BY BREAST IMAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL ELASTOGRAPHY IMAGING MARKET SIZE, BY BREAST IMAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL ELASTOGRAPHY IMAGING MARKET SIZE, BY BREAST IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL ELASTOGRAPHY IMAGING MARKET SIZE, BY LIVER IMAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL ELASTOGRAPHY IMAGING MARKET SIZE, BY LIVER IMAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL ELASTOGRAPHY IMAGING MARKET SIZE, BY LIVER IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL ELASTOGRAPHY IMAGING MARKET SIZE, BY MUSCULOSKELETAL IMAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL ELASTOGRAPHY IMAGING MARKET SIZE, BY MUSCULOSKELETAL IMAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL ELASTOGRAPHY IMAGING MARKET SIZE, BY MUSCULOSKELETAL IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL ELASTOGRAPHY IMAGING MARKET SIZE, BY THYROID IMAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL ELASTOGRAPHY IMAGING MARKET SIZE, BY THYROID IMAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL ELASTOGRAPHY IMAGING MARKET SIZE, BY THYROID IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL ELASTOGRAPHY IMAGING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. AMERICAS ELASTOGRAPHY IMAGING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 51. AMERICAS ELASTOGRAPHY IMAGING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 52. AMERICAS ELASTOGRAPHY IMAGING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 53. AMERICAS ELASTOGRAPHY IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 54. AMERICAS ELASTOGRAPHY IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 55. AMERICAS ELASTOGRAPHY IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 56. NORTH AMERICA ELASTOGRAPHY IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. NORTH AMERICA ELASTOGRAPHY IMAGING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 58. NORTH AMERICA ELASTOGRAPHY IMAGING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 59. NORTH AMERICA ELASTOGRAPHY IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 60. NORTH AMERICA ELASTOGRAPHY IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 61. NORTH AMERICA ELASTOGRAPHY IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 62. LATIN AMERICA ELASTOGRAPHY IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. LATIN AMERICA ELASTOGRAPHY IMAGING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 64. LATIN AMERICA ELASTOGRAPHY IMAGING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 65. LATIN AMERICA ELASTOGRAPHY IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 66. LATIN AMERICA ELASTOGRAPHY IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 67. LATIN AMERICA ELASTOGRAPHY IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 68. EUROPE, MIDDLE EAST & AFRICA ELASTOGRAPHY IMAGING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 69. EUROPE, MIDDLE EAST & AFRICA ELASTOGRAPHY IMAGING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 70. EUROPE, MIDDLE EAST & AFRICA ELASTOGRAPHY IMAGING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 71. EUROPE, MIDDLE EAST & AFRICA ELASTOGRAPHY IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 72. EUROPE, MIDDLE EAST & AFRICA ELASTOGRAPHY IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 73. EUROPE, MIDDLE EAST & AFRICA ELASTOGRAPHY IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 74. EUROPE ELASTOGRAPHY IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. EUROPE ELASTOGRAPHY IMAGING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 76. EUROPE ELASTOGRAPHY IMAGING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 77. EUROPE ELASTOGRAPHY IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 78. EUROPE ELASTOGRAPHY IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 79. EUROPE ELASTOGRAPHY IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 80. MIDDLE EAST ELASTOGRAPHY IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. MIDDLE EAST ELASTOGRAPHY IMAGING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 82. MIDDLE EAST ELASTOGRAPHY IMAGING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 83. MIDDLE EAST ELASTOGRAPHY IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 84. MIDDLE EAST ELASTOGRAPHY IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 85. MIDDLE EAST ELASTOGRAPHY IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 86. AFRICA ELASTOGRAPHY IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. AFRICA ELASTOGRAPHY IMAGING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 88. AFRICA ELASTOGRAPHY IMAGING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 89. AFRICA ELASTOGRAPHY IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 90. AFRICA ELASTOGRAPHY IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 91. AFRICA ELASTOGRAPHY IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 92. ASIA-PACIFIC ELASTOGRAPHY IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. ASIA-PACIFIC ELASTOGRAPHY IMAGING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 94. ASIA-PACIFIC ELASTOGRAPHY IMAGING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 95. ASIA-PACIFIC ELASTOGRAPHY IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 96. ASIA-PACIFIC ELASTOGRAPHY IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 97. ASIA-PACIFIC ELASTOGRAPHY IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL ELASTOGRAPHY IMAGING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 99. ASEAN ELASTOGRAPHY IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 100. ASEAN ELASTOGRAPHY IMAGING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 101. ASEAN ELASTOGRAPHY IMAGING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 102. ASEAN ELASTOGRAPHY IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 103. ASEAN ELASTOGRAPHY IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 104. ASEAN ELASTOGRAPHY IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 105. GCC ELASTOGRAPHY IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. GCC ELASTOGRAPHY IMAGING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 107. GCC ELASTOGRAPHY IMAGING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 108. GCC ELASTOGRAPHY IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 109. GCC ELASTOGRAPHY IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 110. GCC ELASTOGRAPHY IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 111. EUROPEAN UNION ELASTOGRAPHY IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 112. EUROPEAN UNION ELASTOGRAPHY IMAGING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 113. EUROPEAN UNION ELASTOGRAPHY IMAGING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 114. EUROPEAN UNION ELASTOGRAPHY IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 115. EUROPEAN UNION ELASTOGRAPHY IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 116. EUROPEAN UNION ELASTOGRAPHY IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 117. BRICS ELASTOGRAPHY IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 118. BRICS ELASTOGRAPHY IMAGING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 119. BRICS ELASTOGRAPHY IMAGING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 120. BRICS ELASTOGRAPHY IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 121. BRICS ELASTOGRAPHY IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 122. BRICS ELASTOGRAPHY IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 123. G7 ELASTOGRAPHY IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 124. G7 ELASTOGRAPHY IMAGING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 125. G7 ELASTOGRAPHY IMAGING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 126. G7 ELASTOGRAPHY IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 127. G7 ELASTOGRAPHY IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 128. G7 ELASTOGRAPHY IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 129. NATO ELASTOGRAPHY IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 130. NATO ELASTOGRAPHY IMAGING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 131. NATO ELASTOGRAPHY IMAGING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 132. NATO ELASTOGRAPHY IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 133. NATO ELASTOGRAPHY IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 134. NATO ELASTOGRAPHY IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 135. GLOBAL ELASTOGRAPHY IMAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 136. UNITED STATES ELASTOGRAPHY IMAGING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 137. UNITED STATES ELASTOGRAPHY IMAGING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 138. UNITED STATES ELASTOGRAPHY IMAGING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 139. UNITED STATES ELASTOGRAPHY IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 140. UNITED STATES ELASTOGRAPHY IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 141. UNITED STATES ELASTOGRAPHY IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 142. CHINA ELASTOGRAPHY IMAGING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 143. CHINA ELASTOGRAPHY IMAGING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 144. CHINA ELASTOGRAPHY IMAGING MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 145. CHINA ELASTOGRAPHY IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 146. CHINA ELASTOGRAPHY IMAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 147. CHINA ELASTOGRAPHY IMAGING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)